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Abstract 
Lipid transfer proteins (LTPs) are the major allergens of Rosaceae fruits in the Mediterranean area. Pru p 3, the LTP and major allergen of 
peach, is a suitable model for studying food allergy and amino acid sequences related with its IgE-binding capacity. In this work, we sought 
to map IgE mimotopes on the structure of Pru p 3, using the combination of a random peptide phage display library and a three-dimensional 
modelling approach. Pru p 3-specific IgE was purified from 2 different pools of sera from peach allergic patients grouped by symptoms (OAS-pool 
or SYS-pool), and used for screening of a random dodecapeptide phage display library. Positive clones were further confirmed by ELISA assays 
testing individual sera from each pool. Three-dimensional modelling allowed location of mimotopes based on analysis of electrostatic properties 
and solvent exposure of the Pru p 3 surface. Twenty-one phage clones were selected using Pru p 3-specific IgE, 9 of which were chosen using 
OAS-specific IgE while the other 12 were selected with systemic-specific IgE. Peptide alignments revealed consensus sequences for each pool: L37 
R39 T40 P42 D43 R44 A46 P70 S76 P78 Y79 for OAS-IgE, and N35 N36 L37 R39 T40 D43 A46 S76177 P78 for systemic-IgE. These 2 consensus 
sequences were mapped on the same surface of Pru p 3, corresponding to the helix 2-loop-helix 3 region and part of the non-structured C-terminal 
coil. Thus, 2 relevant conformational IgE-binding regions of Pru p 3 were identified using a random peptide phage display library. Mimotopes can 
be used to study the interaction between allergens and IgE, and to accelerate the process to design new vaccines and new immunotherapy strategies. 
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1. Introduction 
Fruits, particularly peach, are the foods most frequently 
involved in allergic reactions in the adult population from the 
Mediterranean area (Ortolani et al., 1988; Kanny et al., 2001; 
Cuesta-Herranz et al., 1998; Cuesta-Herranz et al., 2000). The 
major peach allergen, named Pru p 3, belongs to the lipid transfer 
protein (LTP) panallergen family (Sanchez-Monge et al., 1999; 
Pastorello et al., 1999). This protein family is widely distributed 
throughout the plant kingdom and includes small basic polypep-
tides (9 kDa; p / ~ 9) with 8 conserved cysteine residues forming 
4 disulphide bridges (Salcedo et al., 2004; Salcedo et al., 2007). 
LTPs are important allergens not only in Rosaceae fruits, but 
also in other plant foods, such as vegetables, cereals and nuts 
(Salcedo et al., 2004; Salcedo et al., 2007). Furthermore, LTPs 
have also been involved in some pollinosis and in cross-reactivity 
between plant foods and pollens (Salcedo et al., 2007; Zuidmeer 
and van Ree, 2007), as well as in occupational asthma (baker's 
asthma) (Palacin et al., 2007). 
The standard folding of plant LTP allergens is an all-a-
type compact structure comprising 4 a-helices, firmly held by 
a network of the 4 conserved disulphide bridges, and a non-
structured C-terminal coil (Salcedo et al., 2007; Pasquato et al., 
2006). This compact structure is consistent with their uncommon 
resistance to heat treatment and digestive proteolytic attack, thus 
suggesting that LTP allergens retain most of their immunogenic 
and allergenic capacity after passing through the gastrointestinal 
tract (Salcedo et al., 2007; van Ree, 2002). These characteris-
tics could explain the severe systemic clinical symptoms usually 
associated with LTP-mediated allergies (Fernandez-Rivas et al., 
2003; Pastorello and Robino, 2005), and have led to the propo-
sition of LTPs as a model family of true food allergens, being 
peach Pru p 3 the prototypic member (Salcedo et al., 2007; van 
Ree, 2002). 
The compact folding and high stability of LTP allergens 
suggest that conformational IgE-epitopes represent their main 
IgE-binding structural motifs. Very limited information on IgE-
epitopes of plant food allergens belonging to the LTP family 
is available at present. Only 3 sequential epitopes of Pru p 3 
have been located analyzing synthetic decapeptides deduced 
from its amino acid sequence (Garcia-Casado et al., 2003). 
The restrictions inherent to this approach indicate that poten-
tially relevant IgE-binding regions of this allergen, particularly 
conformational epitopes formed by sequentially discontinu-
ous amino acid residues, have not been described yet. Most 
of antibody epitopes are described to be conformational and 
hence, sequential approaches may render limited informa-
tion, besides might exhibit reduced antibody-affinity (Aalberse, 
2000). 
New strategies have been tested in the last years to study 
and characterize regions with IgE-binding capacity. Phage dis-
play has shown to be a powerful tool to uncover conformational 
mimic epitopes or mimotopes from random peptide phage 
libraries (Luzzago et al., 1993; Folgori et al., 1994). Mimo-
tope sequences would represent a region of the allergen that is 
recognized by IgE, thus representing a structural B-cell epitope 
(Ganglberger et al, 2000; Myers et al., 2000; Davies et al, 2000). 
Mimotopes could also be employed for the development of new 
immunotherapy strategies as design of peptide vaccines or spe-
cific treatments with hypoallergenic proteins (Jensen-Jarolim et 
al, 1998; Jensen-Jarolim et al., 1999). 
The aim of the present work was to define ligands mimicking 
conformational epitopes on the Pru p 3 allergen and to analyze 
the location of such epitopes on its molecular surface by using 
phage-displayed peptide libraries. 
2. Methods 
2.1. Patients and sera 
Sera from 23 peach allergic patients were tested in this study. 
Patients were selected at the Servicio de Alergia, Fundacion 
Jimenez Diaz (Madrid) based on a convincing clinical history 
of allergic reactions after peach ingestion and a positive skin 
prick test (SPT) (Sub-Committee on Skin Tests of the European 
Academy of Allergology and Clinical Immunology, 1989) to 
response to peach (ALK-Abello, Madrid, Spain). On a second 
step, peach allergy was confirmed in all selected patients by an 
open oral challenge test to peach following the method previ-
ously described (Cuesta-Herranz et al., 1998; Cuesta-Herranz et 
al., 2000). Finally, positive SPT response and specific IgE to Pru 
p 3 were also need to take part in the study. Demographic and 
clinical data of these patients are shown in Table 1. Sera were 
grouped in 2 pools according to peach allergic symptoms: OAS-
pool (patients showing only oral allergy syndrome) and SYS 
(systemic)-pool (patients with, at least, one systemic reaction, 
with or without associated OAS). Systemic reactions included 
urticaria (8 patients), angioedema (4 patients) and asthma (2 
patients). The study was approved by the Ethics Committee 
(Hospital Jimenez Diaz) and written informed consent was given 
by all the patients or their legal representatives. 
2.2. Purification of Pru p 3-specific IgE 
Expression of rPru p 3 in Pichia pastoris and isolation of 
the recombinant allergen was performed by methods previ-
ously described (Diaz-Perales et al., 2003). Purified rPru p 3 
was quantified by means of the commercial bicinchoninic acid 
test (Pierce, Cheshire, UK) and used to isolate specific IgE 
from the OAS- and SYS-pool of sera. Briefly, 12 mg of puri-
fied rPru p 3 was dissolved in 0.1 mol/L Na2C02 [pH 8.3] with 
0.5 mol/L NaCl. After washing with 1 mmol/L HCL, BrCN-
activated Sepharose 4B was incubated with the recombinant 
allergen at 4 °C overnight. Then, the matrix was packed and 
equilibrated with 50 mmol/L Tris-HCl [pH 7.5]. Ten millilitres 
of each serum pool (OAS or SYS) was applied to the rPru p 3-
affinity column. After washing with 50 mmol/L Tris-HCl [pH 
7.5], the binding-immunoglobulin was eluted with 0.1 mol/L 
glycine [pH 2.7] with 0.5 mol/L NaCl. After elution, retained 
fraction was equilibrated with 1 mol/L Tris-HCl [pH 8.5]. Pru 
p 3-specific IgG and IgE contained in the retained fraction 
were separated by affinity chromatography with a HiTrap Pro-
tein G HP (GE Healthcare). Purity of IgE and IgG fractions 
was checked by ELISA assays using each fraction as solid 
phase (0.1 (ig/mL), and anti-human IgE-HRP polyclonal anti-
body (DAKO; 1/5000 dilution). Values (OD units at 492 nm) 
obtained in the OAS-pool were 1.24, 2.07 and 0.31 for the 
whole pool of sera, the specific IgE fraction and the spe-
cific IgG fraction, respectively, and 1.24, 1.67 and 0.22 for 
the whole pool of sera and the specific IgE and IgG, respec-
tively, in the case of the SYS-pool. A pool of sera from 
5 atopic subjects with allergy to house dust mites but not 
to plant foods or pollens was used as negative control (OD 
units = 0.124). 
2.3. Biopanning of phage display library and colony 
screening 
The Ph.D.-12 Phage Display Peptide Library (2.7 x 
109clones; New England Biolabs) was used to select phage 
clones that bound Pru p 3-specific IgE. The M13-phage used 
contained a modified P8 coat protein, the most abundant in its 
surface, in which a random dodecapeptide had been inserted. 
Panning was performed following the manufacturer's instruc-
tions. Pru p 3-specific IgE coating plates were incubated with 
phages, and the bound clones were eluted with glycine buffer 
Table 1 
Clinical data of the selected patients 
Patients Age Sex OAS SYS Pollen allergy Pra p 3 (SPT) Specific-IgE to Pru p 3a (OD units) 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
23 
20 
21 
12 
21 
34 
37 
32 
30 
66 
21 
39 
24 
43 
33 
4 
26 
45 
40 
13 
11 
15 
26 
F 
F 
M 
F 
M 
F 
F 
M 
F 
F 
F 
F 
F 
F 
F 
M 
M 
M 
M 
F 
M 
F 
F 
U,AE 
U 
u 
U,AE 
U,AE 
U 
u 
U,A 
U, AE, A 
0.827 
0.507 
0.640 
0.634 
0.522 
0.400 
0.477 
0.927 
0.647 
1.204 
0.367 
0.420 
1.317 
0.610 
1.297 
0.767 
1.753 
0.840 
1.777 
1.327 
1.023 
1.193 
0.437 
OAS: oral allergy syndrome, SYS: systemic symptoms, M: male, F: female, SPT: skin prick test, OD: optical density, U: urticaria, AE: angioedema, A: asthma. 
a
 Values are means (n = 3). OD higher than 0.189 units were considered positive (see Section 2). 
(0.1 mol/L, pH 2.2). After 3 rounds of selection, 20 phage clones 
from each serum pool were isolated, amplified, and their reactiv-
ity tested with Pru p 3-specific IgE by means of capture ELISA, 
as described below. The amino acid sequences of inserted pep-
tides were deduced by sequencing DNA of the selected clones 
with a specific 5' primer: CGGGAGTATCAATCGCATTGC. 
The used method to DNA sequencing was the ABI PRISM Dye 
Terminator Kit and ABI 3100 sequencer (PerkinElmer Biosys-
tem). 
2.4. ELISA assays 
Pru p 3-specific IgE was determined in each individual serum 
(1:3 dilution) from peach allergic patients by means of a pre-
viously described direct ELISA method (Diaz-Perales et al., 
2003). rPru p 3 (5 (ig/mL) was used as solid phase, and BSA 
(1% in PBS buffer) as negative control. Specific IgE levels 
greater than 0.189 OD units (mean [OD] + 3 x S.D. to BSA) 
were considered positive. All tests were performed in tripli-
cate. 
The specificity of IgE/selected phages recognition was 
confirmed by 2 different ELISA assays. First, plates were 
coated with the selected clones (108 PFU/well) and, after 
blocking, incubated with individual sera (1:3 dilution) from 
the selected patients, then with anti-human IgE-peroxidase-
conjugated antibodies (DAKO; 1:5000 dilution), and finally 
revealed with peroxidase substrate buffer (DAKO). Second, Pru 
p 3-specific IgE (10 (xg/mL)-coated plates were treated with each 
selected clone (108 PFU/well), then with anti-M13-peroxidase-
conjugated monoclonal antibody (GE Healthcare Bioscience; 
1:1000 dilution), and finally revealed with peroxidase substrate 
buffer. The empty Ml3 phage clone was used as negative con-
trol, and OD values of greater than mean [OD] + 3 x S.D. to 
this negative control were considered positive. All tests were 
performed in triplicate. 
2.5. Location ofmimotopes on the structure and surface of 
Prup 3 
Chain A of the X-ray structure of Pru p 3, PDB 
code 2B5S (Pasquato et al., 2006), was used to com-
pute the solvent-excluded surface (SES) with PyMOL 0.99 
(pymol.sourceforge.net). SES areas and relative accessibility 
values of each residue with respect to reference data were 
calculated with Arvomol 4.0 (Pacios, 1994) as explained else-
where (Pacios, 2001). The electrostatic Poisson-Boltzmann 
(PB) potential mapped onto the protein surface was obtained 
with APBS 0.4.0 (Baker et al., 2001) assigning AMBER99 
(Wang et al., 2004) atomic charges and radii, including hydro-
gens that were added with PDB2PQR (Dolinsky et al., 2004). 
Fine (0.50 A spacing) grids around the 1293 resulting atoms 
were used to solve the nonlinear PB equation in sequential-
focusing multigrid calculations in a mesh of 97 points per 
dimension at 298.15 K with dielectric constants 2 for the pro-
tein and 78.54 for water. Potential values are given in units 
of kT per unit charge (k, Boltzmann's constant; T, absolute 
temperature). Molecular graphics were rendered with PyMOL 
0.99. 
3. Results 
3.1. Selection of Pru p 3-specific IgE-binding phage clones 
Positive SPT response to Pru p 3 were observed in all 23 
selected patients and significant specific IgE to this allergen 
found in all corresponding sera (Table 1). Two different serum 
pools were obtained according to the patients' symptoms: OAS-
pool (sera 1-14) and SYS (systemic)-pool (sera 15-23). Pru p 
3-specific IgE from each pool was purified by a two-step method 
of affinity chromatography, which included a Pru p 3-Sepharose 
column followed by a Hitrap Protein G HP Column to separate 
Pru p 3-specific IgE and IgG (see Section 2). 
The purified Pru p 3-specific IgE fractions from both pools of 
sera were independently used to screen a random display peptide 
phage library to select IgE-binding phage clones. Twenty clones 
were chosen for each type of Pru p 3-specific IgE (OAS- or 
SYS-pool) after 3 rounds of selections. Sequencing of the DNA 
insertions of each selected clone rendered 9 different peptides 
for the purified specific IgE from the OAS-pool, and 12 distinct 
peptides for that from the SYS-pool. The amino acid sequences 
of all these peptides are shown in Table 2. 
Several individual sera forming each pool recognized each 
selected phage clone (Table 2). Interestingly, 6 out of 9 clones 
selected with the OAS-pool-specific IgE, as well as 9 out of 12 
clones with the SYS-pool-specific IgE, were recognized by more 
than 50% of the corresponding individual sera, thus supporting 
the selection procedure. None of the individual sera recognized 
the wild Ml3 phage (whose P8 coating protein was not modified 
by peptide insertion). 
3.2. Specificity of the binding between Pru p 3-specific IgE 
and selected phage clones 
The specificity of the IgE/phage clone binding was further 
analyzed by means of ELIS A assays using rPru p 3-specific IgE-
coated plates incubated with each selected clone. The binding 
was detected with an anti-M13-peroxidase-conjugated mono-
clonal antibody. The results are summarized in Fig. 1. All the 
selected phage clones bound to the corresponding (OAS- or 
SYS-pool) rPru p 3-specific IgE. However, substantial differ-
ences in the absorbance among the selected clones were noticed, 
suggesting that some mimotopes showed more affinity to IgE 
than others. 
3.3. Identification of IgE-epitopes in the structure of Pru p 3 
The amino acids of mimotope sequences were ordered 
according with the frequency of apparition. Thus, the most 
frequent amino acid (which appeared in the greater number 
Table 2 
Amino acid sequence of inserted peptides from the selected clones and their recognition by the individual sera forming each pool sera and alignment 
OAS-pool 
SYS-pool 
Phage 
1 
2 
3 
4 
5 
6 
7 
8 
9 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
Peptide sequence 
RNTRHPPPWSAE 
WPGSNLTPRTQT 
L I K T S P R S E R Y A 
SVSVGCKPVPRP 
SHLLKPQTRTRT 
QLSGTLERQWQR 
V L P P A L E I T P L T 
V I P L A I E F T P R P 
A Q V T L P I R T P N A 
LTRGSPVTGPFA 
S L G A A Q W L P R T 
NTDSALRLPPFY 
SLTPLLFNYDVA 
FHAEWPTPSPWP 
NDDLMATRHGLA 
KSNDLGSAPLQH 
TDHSMGQRVQPS 
RWWQHRPSHTPS 
HNTVPSLWYHNR 
QLSGMLEWQNLR 
TPTGVHIAPVQT 
Recognition by individual sera 
6/14 
7/14 
11/14 
12/14 
11/14 
2/14 
6/14 
9/14 
10/14 
5/8 
4/8 
8/8 
7/8 
8/8 
6/8 
7/8 
4/8 
7/8 
6/8 
8/8 
4/8 
Consensus 
Consensus 
Aligment 
[sasaaaffl 
iS3BQTTiGNB 
jggjsglgYggJ 
I S H V H C V G B V 
n—OBTT.THWI 
QB3JL[SQ[^GQQ 
QITQ3VQ3LQLQ 
g [3E S3 S H 
EASEVIQT^NJ! 
EHESGFVfflPT 
a s j a S E (3 
33323S33S 
H3LMMSJ8VYF 
HapHSIwwEPPFEl 
ETrl3r kUHMfiiaJi 
s sKJ^jEfgEi 
liifeidsiMsvclSSSgi 
JE35HWWRP^S|J] 
BBHHflWTsllVYi 
LBHMWHQEJBN 
HTTHSITWPBISS 
The peptide sequences are aligned in the right column and a consensus sequence for each group of peptides is remarked. 
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Fig. 1. Pru p 3-specific IgE/selected phage clone binding. ELISA assays were performed using the corresponding specific IgE (OAS or SYS) as solid phase and 
each selected phage clones. Empty (non-modified) M13 clone was tested as negative control. Means (n = 3) and S.D. (bars) are represented. Horizontal lines indicate 
cut-off values (see Section 2). 
of clones) was ordered in the first position. The alignment 
of this sequences (Table 2) revealed a remarkable similarity 
that leads to the consensus sequences PSRTPRPEWAXL for 
OAS-lgE selected clones and TSRPALLNDQGH for SYS-lgE 
clones. Amino acids in these 2 sequences were mapped onto 
the structure of Pru p 3 (Pasquato et al., 2006) by select-
ing residues located at the protein surface that exhibit proper 
electrostatic and solvent exposure features (Garcia-Casado et 
al., 2003; Dolinsky et al., 2004) and choosing analogous 
amino acids to replace those absent in Pru p 3 (D for E or 
Y for W, for instance). The resulting mimotope for OAS-
lgE clones was composed of the residues (arranged in Pru 
p 3 sequence ordering) L37R39T40P42D43R44A46P70S76P78Y79 
whereas for SYS-lgE clones the mimotope lacks the last H 
(Pru p 3 has no histidines) and was composed of the residues 
N35N36L37R39T4oD43A46S76l77P78. These amino acids are 
P42 
•A. 
(A) 
+4.0 
(3) (C) 
Fig. 2. Amino acids in OAS and SYS mimotopes on Pru p 3. (A) Ribbon diagrams, (B) Surfaces. Residues shared by both mimotopes are coloured yellow, those 
present only in the OAS mimotope are coloured salmon and those present only in the SYS mimotope are coloured blue. (C) Electrostatic PB potential mapped onto 
the surface. Bottom views of Fig. 2A through C are derived from upper views by means of a clockwise 90° rotation about a vertical axis. 
located in 2 separate parts of the structure of Pru p 3 (Fig. 2A): 
the close ends of helices 2 and 3 together with their connecting 
loop (residues 35^16) and a short segment in the non-structured 
coil at the C-terminus (residues 76-79). 
Despite being structurally far apart, the mimotopes happen to 
be located at the same surface region spanning a contiguous area 
of 910 A2 (the total protein area is 4850 A2) in which 9 out of 
the 14 residues have percentages of exposure to solvent greater 
than 60%. The mimotopes share 7 residues, L37, R39, T40, D43, 
A46, S76 and P78, that form a connected surface with an expo-
sure to the solvent noticeably greater than the non-overlapping 
residues R44, P70 and Y79 in the OAS-IgE mimotope, and N35 
and I77 in the SYS-IgE mimotope (Fig. 2B). These results agree 
with the known fact that B-cell epitopes are usually associated 
with turns or loops and exposed regions protruding from protein 
surfaces and strongly suggest that OAS and SYS mimotopes are 
involved in the same IgE-binding region of Pru p 3. The surface 
covered by the mimotopes exhibits an electrostatic potential in 
which intermediate positive values dominate (Fig. 2C) although 
N35 and R44 show greater electropositive values (Fig. 2C, top). 
Small electronegative areas are noticed around N36 and the 
unique acidic residue in Pru p 3, D43 (Fig. 2C, top), as well 
as in a large part of the S76 area (Fig. 2C, bottom) which is 
by far the most protruding residue (94% exposure to the sol-
vent). This way, the area spanned by these 5 residues forms a 
patch with alternating electrostatic potential in the vicinity of the 
H2H3 loop. 
4. Discussion 
Results of this manuscript showed at the first time identi-
fication of 2 relevant conformational epitopes of Pru p 3 by 
using a random peptide phage display library. The importance 
of these findings is based on this information will help to gen-
erate hypoallergenic variants of major allergens which might 
be potentially used in specific immunotherapy (Ferreira et al., 
2002; Larche et al, 2006). A previous knowledge of the B (IgE) 
epitopes, both sequential and conformational, as well as of T-cell 
epitopes, is required to design these engineered variants. This 
information is very scarce for IgE-epitopes (Garcia-Casado et 
al., 2003) and non-existing for the T-cell epitopes in the case of 
plant food LTP allergens. Novel data on conformational epitopes 
of peach Pru p 3, the allergen model of the plant food LTP family, 
have been obtained here by means of mimotope identification. 
Analysis of phage display random peptide libraries using spe-
cific IgE to an allergen allows uncover peptides that mimic the 
binding site for IgE but do not correspond to the linear sequence 
of the cognate allergen. These peptides are known as mimo-
topes and usually represent conformational epitopes (Riemer et 
al, 2004). 
Peach allergy mediated by Pru p 3 can be related with mild 
reactions restricted to the orapharyngeal cavity (oral allergy syn-
drome, OAS), frequently associated with pollinosis (Ortolani et 
al., 1988; Cuesta-Herranz et al., 2000; Zuidmeer and van Ree, 
2007; Fernandez-Rivas et al., 2003). Besides, severe systemic 
symptoms are developed by many patients (around 30%) suffer-
ing this allergy, with or without associated pollinosis (Zuidmeer 
and van Ree, 2007; Fernandez-Rivas et al., 2003; Fernandez-
Rivas et al., 1997). Therefore, Pru p 3-specific IgE was isolated 
from 2 different serum pools: OAS-pool (including sera from 
patients who showed exclusively OAS), and SYS-pool (formed 
by sera from patients who had suffered at least a systemic reac-
tion, with or without linked OAS). Specific IgE from both pools 
was independently used to perform 3 sequential rounds of par-
allel screenings of a phage-displayed random peptide library. 
Nine and 12 different clones were finally selected for OAS-
and SYS-IgE, respectively, after DNA sequencing of 20 IgE-
binding clones detected with each pool. Most of the selected 
clones were recognized by more than 50% of the individual 
sera that comprise the corresponding pool, thus highlighting 
the specificity of the selection method and the relevance of 
the detected mimotopes. Furthermore, all selected phage clones 
bound the isolated Pru p 3-specific IgE (from the OAS- or SYS-
pool), although different relative responses (OD units) were 
observed, probably reflecting differences in the mimotope affin-
ity to IgE. 
The alignment of amino acid of the selected pep-
tides generated 2 consensus mimotopes (Table 2) which 
were mapped onto the structure of Pru p 3 to the frag-
ments L37R39T40P42D43R44A46P70S76P78Y79 for OAS-IgE 
and N35N36L37R39T40D43A46S76I77P78 for SYS-IgE clones 
(Fig. 2A). These 2 sequences share 7 residues and correspond 
to amino acids located at the loop H2H3 and at a short seg-
ment in the C-terminal coil. In spite of their separation in 
the 3D allergen structure, both mimotopes span contiguous 
areas at the same region of the protein (Fig. 2B), a result 
which points to their common involvement in the interaction 
with IgE. The dominance of protruding areas (two thirds of 
the residues in the mimotopes have percentages of exposure 
greater than 60%) and the presence of a region with alternat-
ing sign in the electrostatic potential (Fig. 2C) are compatible 
with favourable antigen-antibody interactions. However, given 
the homogeneous electropositive nature and the magnitude of the 
PB potential values (Fig. 2C), it seems also reasonable to predict 
a weak ionic activity associated to these IgE-binding surfaces. 
Since it has been proposed that strong electrostatic interactions 
should be expected in high-affinity antibody-antigen complexes 
whereas weaker electrostatic activity inherent to less specific 
contacts should be indicative of cross-reactivity (Sinha et al., 
2002), one can speculate that these surfaces should preferably 
exhibit cross-reactive behaviour. 
Regardless the nature of the IgE-binding interactions, the 
results provided by OAS and SYS mimotopes taken together 
point clearly to a particular surface region of Pru p 3 (Fig. 2) 
which has emerged before from rather different approaches. It 
must be stressed that the surface areas depicted by both mimo-
topes nicely match a great part of the IgE-epitopes previously 
reported by our group after following different methodologies 
(Garcia-Casado et al., 2003). For instance, on the theoreti-
cal basis of individual exposure and electrostatic features of 
all the amino acids of Pru p 3, residues N36, R39, T40, R44 
and S76 were proposed to participate actively in IgE binding 
and indeed, a triple mutant R39A/T40A/R44A exhibited a 5-
fold decrease in the IgE-binding capacity compared with the 
Allergen IgE-binding region Common residues 
35 4676 79 
Prup3 NNLRTPDRASIPY 
Pruar3 NNLRTPDRTNIPY 11/13 
Prud3 NNLRTADRANVPY 10/13 
Zeaml4 NNARTADRASIPY 9/13 
Mald3 NGLRTADRTNVPY 8/13 
Pru av 3 NNLKTADRTNVPY 8/13 
Cits 3 NAARTPDRTSIPY 8/13 
Hcvbl2 NNAKTADRTNIPY 8/13 
Cor a 8 NDARTSDRSNIPY 8/13 
Fraa3 NSMKTADRQNVPY 7/13 
Vitvl NSAKTGDRASVPY 7/13 
Tfial4 HNQRSSDRSNLPY 7/13 
Amba6 NNSKTADRAVKPD 7/13 
Lyce3 LGQKTVDRANIPY 6/13 
Par j1 DGEKTLQRHVDSK 3/13 
Parj2 SEEKTEQKETTT- 1/13 
Fig. 3. Alignment of the amino acid sequence of the IgE-binding region of Pru p 3 defined here with the equivalent sequence of LTP allergens. Position numbers 
correspond to the Pru p 3 sequence. 
native allergen (Garcia-Casado et al., 2003). Moreover, results 
of immunoblots with synthetic decapeptides overlapping by 5 
amino acids together with theoretical analyses led us to iden-
tify 3 IgE-epitopes composed of the sequence segments 10-25, 
31^5 and 71-80 (Garcia-Casado et al, 2003). Note that all the 
residues in OAS and SYS mimotopes here described happen 
to be included in the second and third epitope, except A46 and 
P70 that correspond just to the end positions between these 2 
segments. Regarding the first epitope, non-detected here, it is 
interesting to note that the segment 10-25 has been reported 
to overlap with one relevant region involved in IgE recogni-
tion described in Par j 1, a major allergen of Parietaria pollen 
(Colombo etal., 1998). 
The fair agreement between the surface area of Pru p 3 with 
IgE-binding capacity identified here and the regions proposed 
before as potential epitopes by our group can be overempha-
sized. Given the rather different methodological nature of phage 
display technology employed in this work to derive mimotopes 
and immunoblots with synthetic peptides or the fully theoreti-
cal approaches considered in our previous research to identify 
epitopes, this coincidence must be highlighted. The contiguous 
surface area spanned by residues near the loop H2H3 together 
with the sequence segment 76-79 in the C-terminus seems thus 
a strong candidate to an ultimate IgE-binding region on this 
benchmark member of the LTP panallergens. 
The alignment of the amino acid sequence of the Pru p 3 
IgE-binding region here defined with the equivalent sequences 
of allergic LTPs from several plant foods and pollens (Fig. 3) 
indicated a high variability in the degree of similarity to the 
Pru p 3 region. Such similarity could determine the frequency 
of cross-reactions among several Rosaceae fruits found in the 
Mediterranean population, as well as between peach and some 
vegetables or nuts (Salcedo et al., 2007). Conversely, the diver-
gence detected in several LTP allergens could also explain 
the limited (wheat Tri a 14), or even null cross-reactivity 
(Parietaria Par j 1) described between peach and wheat or 
peach and these pollens (Salcedo et al., 2007; Palacin et al., 
2007). 
The power of the phage display technique must be finally 
highlighted as the results presented in this work are in excel-
lent agreement with others reported before (Garcia-Casado et 
al., 2003; Borges et al., 2007). This technique can be espe-
cially important in food allergens as LTPs that involve mainly 
conformational epitopes. A wider use of this technique might 
undoubtedly facilitate the characterization of IgE-epitopes on 
different allergens (Riemer et al., 2004; Sharav et al., 2007; 
Partidos and Steward, 2002). 
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